Account Info
Log Out
English
Back
Log in to access Online Inquiry
Back to the Top

Update

$Fortress Biotech(FBIO.US)$ $Mustang Bio(MBIO.US)$ City of Hope-developed Chimeric Antigen Receptor (CAR) T Cell Therapy Shows Clinical Activity in Patients With Aggressive Brain Tumors in a Phase 1 Trial
4 MINUTES AGO, 5:00 AM EST
VIA BUSINESSWIRE

Half of the enrolled patients had stable disease for at least two months, two showed partial response and two experienced complete response
Nature Medicine paper highlights delivery of CAR T cell therapy directly to the brain, a technique City of Hope developed
This is the largest reported trial to date of CAR T therapy for solid tumors
Disclaimer: Community is offered by Moomoo Technologies Inc. and is for educational purposes only. Read more
2
+0
5
Translate
Report
5142 Views
Comment
Sign in to post a comment
1819Followers
29Following
22KVisitors
Follow